Divisional EBIT: Medical Centres down 10.9% to $85.9m, Pathology up 5.9% to $134.9m, Imaging down 26.5% to $25.2m, Corporate down 7.6% to $49.7m | Net operating cash flow up 19% to $285.1m | Strategic transformation gaining momentum with the introduction of capital‐light healthcare practitioner recruitment packages, re‐focus on core activities to drive improved returns and investment for growth.